<sup>18</sup>F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axis
Yuchen Jiang(Shanghai Institute of Materia Medica), Ruimin Huang(Shanghai Institute of Materia Medica)
Cited by 11
Related Papers
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
|Acta Pharmacologica Sinica|2018|66
Selective N-glycan editing on living cell surfaces to probe glycoconjugate function
|Nature Chemical Biology|2020|64
Metabolic benefits of inhibition of p38α in white adipose tissue in obesity
|PLoS Biology|2018|44
Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling
|BMC Complementary Medicine and Therapies|2020|11